Center-Authored Papers

Filters: Author is Anderson, Garnet  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhou Y, Chlebowski R, Lamonte MJ, Bea JW, Qi L, Wallace R, Lavasani S, Walsh BW, Anderson G, Vitolins M et al..  2014.  Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: Results from the Women's Health Initiative.. Gynecologic oncology. 133(1):4-10. Abstract
Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SAA et al..  2014.  Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.. Breast cancer research : BCR. 16(2):R30. Abstract
Y
Yuan C, Clish CB, Wu C, Mayers JR, Kraft P, Townsend MK, Zhang M, Tworoger SS, Bao Y, Qian ZR et al..  2016.  Circulating Metabolites and Survival Among Patients With Pancreatic Cancer.. Journal of the National Cancer Institute. 108(6):djv409. Abstract
W
Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita BH, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, LaCroix AZ et al..  2010.  Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.. Cancer research. 70(3):1015-23. Abstract
Whitsel EA, Quibrera MP, Christ SL, Liao D, Prineas RJ, Anderson GL, Heiss G.  2009.  Heart rate variability, ambient particulate matter air pollution, and glucose homeostasis: the environmental epidemiology of arrhythmogenesis in the women's health initiative.. American journal of epidemiology. 169(6):693-703. Abstract
U
Urban ND, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, Manson JE, Palomares MR, Daly MB, Wactawski-Wende J et al..  2015.  Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.. Gynecologic oncology. 139(2):253-260. Abstract
Urban ND, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD et al..  2011.  Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer.. Journal of the National Cancer Institute. 103(21):1630-4. Abstract
T
Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ et al..  2016.  Circulating estrogens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, Sarto G, Parker LM, Modugno F, Anderson GL.  2008.  The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative.. Nutrition and cancer. 60(6):710-9. Abstract
Taylor KC, Carty CL, Dumitrescu L, Bůžková P, Cole SA, Hindorff L, Schumacher FR, Wilkens LR, Shohet RV, Quibrera MP et al..  2013.  Investigation of gene-by-sex interactions for lipid traits in diverse populations from the population architecture using genomics and epidemiology study.. BMC genetics. 14:33. Abstract
S
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Smith HO, Moon J, Wilczynski SP, Tiersten AD, Hannigan EV, Robinson WR, Rivkin SE, Anderson GL, Liu P-Y, Markman M.  2009.  Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.. Gynecologic oncology. 114(2):206-9. Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose PV et al..  2015.  Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.. Journal of the National Cancer Institute. 107(4) Abstract
Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R et al..  2008.  Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(9):2647-55. Abstract
Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M et al..  2017.  Genome-wide association study identifies multiple risk loci for renal cell carcinoma.. Nature communications. 8:15724. Abstract
R
Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC et al..  2014.  Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study.. Annals of internal medicine. 160(9):594-602. Abstract
Rossouw JE, Manson JE, Kaunitz AM, Anderson GL.  2013.  Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.. Obstetrics and gynecology. 121(1):172-6. Abstract
Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-Laforce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE et al..  2013.  Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.. American journal of obstetrics and gynecology. Abstract
P
Prentice RL, Manson JE, Anderson GL, LaCroix AZ, Shumaker SA, Chlebowski RT, Howard BV, Stefanick ML, Jackson RD, Wactawski-Wende J et al..  2013.  Women's Health Initiative View of Estrogen Avoidance and All-Cause Mortality.. American journal of public health. 103(12):e2.
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH et al..  2008.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
Prentice RL, Pettinger M, Tinker LF, Huang Y, Thomson CA, Johnson KC, Beasley J, Anderson G, Shikany JM, Chlebowski RT et al..  2013.  Regression Calibration in Nutritional Epidemiology: Example of Fat Density and Total Energy in Relationship to Postmenopausal Breast Cancer.. American journal of epidemiology. 178(11):1663-72. Abstract
Prentice RL, Anderson GL.  2008.  The women's health initiative: lessons learned.. Annual review of public health. 29:131-50. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH, Lane DS et al..  2008.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.. American journal of epidemiology. 167(10):1207-16. Abstract